Table 3. QoL scores at subsequent clinic visits, correlated with ≥6 mo survival.
Visit | 95% two-sided CL | QoL scores |
P value | |
---|---|---|---|---|
≥6 mo survival | <6 mo survival | |||
1 (initial day of treatment) | Lower | 0.088 | ||
Mean | 39.314 | 39.705 | ||
Std Dev | 6.0914 | 9.8603 | ||
Mean estimate | ||||
Mean | 42 | 53.857 | ||
Std Dev | 7.5746 | 15.302 | ||
Upper | ||||
Mean | 44.686 | 68.009 | ||
Std Dev | 10.019 | 33.695 | ||
Std Err | 1.3186 | 5.7835 | ||
Total | 33 | 7 | ||
2 (3 weeks into treatment) | Lower | 0.0092 | ||
Mean | 35.635 | 45.359 | ||
Std Dev | 8.6039 | 6.6266 | ||
Mean estimate | ||||
Mean | 39.759 | 56.5 | ||
Std Dev | 10.842 | 10.616 | ||
Upper | ||||
Mean | 43.883 | 67.641 | ||
Std Dev | 14.663 | 26.037 | ||
Std Err | 2.0133 | 4.334 | ||
Total | 29 | 6 | ||
3 (6 weeks into treatment) | Lower | 0.0081 | ||
Mean | 33.124 | 40.988 | ||
Std Dev | 6.6836 | 5.8808 | ||
Mean estimate | ||||
Mean | 36.481 | 49.429 | ||
Std Dev | 8.487 | 9.1261 | ||
Upper | ||||
Mean | 39.839 | 57.869 | ||
Std Dev | 11.631 | 20.096 | ||
Std Err | 1.633 | 3.4493 | ||
Total | 27 | 7 |
QoL, quality-of-life; mo, months; CL, confidence limits.